Chas McKhann

CIK: 0001631746

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (40.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

XGN

EXAGEN INC.

Director

COCH

Envoy Medical, Inc.

Director

SILK

Silk Road Medical Inc

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

XGN
EXAGEN INC.
Jun 9, 2026
Award(A)
Stock Option(right to buy)
Direct
37.5K shares-
COCH
Envoy Medical, Inc.
Apr 15, 2026
Award(A)
Stock Option (Right to Buy)
Direct
100K shares-
SILK
Silk Road Medical Inc
Sep 17, 2024
Disposition(D)
Direct
722.4K shares-
SILK
Silk Road Medical Inc
Sep 17, 2024
Award(A)
Direct
1.3M shares-
SILK
Silk Road Medical Inc
Sep 17, 2024
Disposition(D)
Direct
1.3M shares-

		Type	Shares	Price		Ownership
Jun 9, 2026	XGN EXAGEN INC.	Award(A) Stock Option(right to buy)	37,500	-	-	Direct
Apr 15, 2026	COCH Envoy Medical, Inc.	Award(A) Stock Option (Right to Buy)	100,000	-	-	Direct
Sep 17, 2024	SILK Silk Road Medical Inc	Disposition(D)	722,396	-	$0	Direct
Sep 17, 2024	SILK Silk Road Medical Inc	Award(A)	1,299,042	-	$0	Direct
Sep 17, 2024	SILK Silk Road Medical Inc	Disposition(D)	1,299,042	-	$0	Direct

1-5 of 5 transactions

About McKhann Chas

McKhann Chas (SEC CIK 0001631746) files insider reports with the SEC as Director of EXAGEN INC. (XGN), Director of Envoy Medical, Inc. (COCH) and Chief Executive Officer of Silk Road Medical Inc (SILK).

Signal8 holds 6 ownership filings by McKhann Chas (3 Form 3, 3 Form 4), filed between Sep 18, 2024 and Jun 22, 2026. Those filings report 5 transactions, from Sep 17, 2024 to Jun 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on McKhann Chas's filings is in VISTA, CA.

Recent filings by McKhann Chas

Jun 9, 2026: Grant or award of XGN derivative securities (Form 4, code A).
Apr 15, 2026: Grant or award of COCH derivative securities (Form 4, code A).
Sep 17, 2024: Disposition to issuer transaction of SILK shares (Form 4, code D).
Sep 17, 2024: Grant or award of SILK shares (Form 4, code A).
Sep 17, 2024: Disposition to issuer transaction of SILK shares (Form 4, code D).

Other insiders filing for EXAGEN INC. (XGN)

Nova Tina Susan, Director
Chernett Jorey, 10% Owner
ABALLI JOHN, President and CEO
Black Jeffrey G., Chief Financial Officer
Robertson Bruce C, Director
Kim Paul, Director

How to read Form 4 transaction codes